Name Brand Drug Cos. Ax Labeling Claims In Zantac MDL
By Emily Field · January 11, 2021, 8:52 PM EST
A Florida federal judge presiding over sprawling multidistrict litigation involving the carcinogens found in the heartburn medication Zantac cut more claims on Friday from the litigation, holding that design defect claims...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login